| Primary |
| Pneumonia |
19.6% |
| Drug Use For Unknown Indication |
14.5% |
| Peritonitis |
7.1% |
| Infection |
5.9% |
| Hypertension |
5.5% |
| Fluid Replacement |
4.7% |
| Otitis Externa |
4.7% |
| Gastritis |
3.9% |
| Diabetes Mellitus |
3.5% |
| Pancreatitis |
3.5% |
| Pleurodesis |
3.5% |
| Chronic Respiratory Failure |
3.1% |
| Infection Prophylaxis |
3.1% |
| Nutritional Support |
3.1% |
| Asthma |
2.4% |
| Insomnia |
2.4% |
| Lung Neoplasm Malignant |
2.4% |
| Pseudomonas Infection |
2.4% |
| Staphylococcal Sepsis |
2.4% |
| Urinary Tract Infection |
2.4% |
|
| Wheezing |
15.1% |
| Hepatic Function Abnormal |
11.6% |
| Shock |
8.1% |
| Pyrexia |
7.0% |
| Liver Disorder |
5.8% |
| Toxic Epidermal Necrolysis |
5.8% |
| Speech Disorder |
4.7% |
| Cystitis Haemorrhagic |
3.5% |
| Hallucination |
3.5% |
| Intestinal Dilatation |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Platelet Count Decreased |
3.5% |
| Renal Disorder |
3.5% |
| Rhinorrhoea |
3.5% |
| Small For Dates Baby |
3.5% |
| Unresponsive To Stimuli |
3.5% |
| Urine Output Decreased |
3.5% |
| Alanine Aminotransferase Increased |
2.3% |
| Alopecia |
2.3% |
| Drug Level Increased |
2.3% |
|
| Secondary |
| Sepsis |
12.2% |
| Pneumonia |
10.0% |
| Epilepsy |
8.3% |
| Pyrexia |
6.7% |
| Sedation |
6.7% |
| Systemic Mycosis |
5.6% |
| Pancreatitis |
5.0% |
| Vitamin Supplementation |
5.0% |
| Infection |
4.4% |
| Wound Infection Staphylococcal |
4.4% |
| Lung Transplant |
3.9% |
| Anaesthesia Procedure |
3.3% |
| Cancer Pain |
3.3% |
| Diuretic Therapy |
3.3% |
| Hypertension |
3.3% |
| Mineral Supplementation |
3.3% |
| Drug Use For Unknown Indication |
2.8% |
| Gastric Ulcer |
2.8% |
| Graft Versus Host Disease |
2.8% |
| Immunodeficiency Common Variable |
2.8% |
|
| Hepatic Function Abnormal |
17.4% |
| Sepsis |
15.2% |
| Renal Impairment |
13.0% |
| Renal Failure Acute |
10.9% |
| Acute Respiratory Distress Syndrome |
6.5% |
| Toxic Epidermal Necrolysis |
6.5% |
| Renal Disorder |
4.3% |
| Stomatitis |
4.3% |
| Thrombosis |
4.3% |
| Eosinophilic Pneumonia |
2.2% |
| Hyperkalaemia |
2.2% |
| Oral Mucosal Erythema |
2.2% |
| Pleural Effusion |
2.2% |
| Pneumonitis |
2.2% |
| Thrombocytopenia |
2.2% |
| Urine Output Decreased |
2.2% |
| Vomiting |
2.2% |
|
| Concomitant |
| Prophylaxis |
14.0% |
| Product Used For Unknown Indication |
12.2% |
| Pneumonia |
10.6% |
| Neoplasm Malignant |
5.9% |
| Drug Use For Unknown Indication |
5.0% |
| Infection Prophylaxis |
4.8% |
| Immunosuppression |
4.7% |
| Acute Myocardial Infarction |
4.5% |
| Pyrexia |
4.2% |
| Stem Cell Transplant |
4.2% |
| Infection |
4.1% |
| Crohn's Disease |
3.7% |
| Hypertension |
3.4% |
| Constipation |
3.3% |
| Sepsis |
3.0% |
| Acute Myeloid Leukaemia |
2.7% |
| Allogenic Bone Marrow Transplantation Therapy |
2.7% |
| Insomnia |
2.5% |
| Transfusion |
2.3% |
| Interstitial Lung Disease |
2.1% |
|
| White Blood Cell Count Decreased |
15.6% |
| Thrombocytopenia |
7.8% |
| Renal Impairment |
7.1% |
| Sepsis |
6.4% |
| Rhabdomyolysis |
5.7% |
| Septic Shock |
5.7% |
| Interstitial Lung Disease |
4.3% |
| Pancytopenia |
4.3% |
| Platelet Count Decreased |
4.3% |
| Pneumonia |
4.3% |
| Tuberculosis |
4.3% |
| Vomiting |
4.3% |
| Lung Disorder |
3.5% |
| Pneumonia Cytomegaloviral |
3.5% |
| Pyrexia |
3.5% |
| Renal Disorder |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Cytomegalovirus Viraemia |
2.8% |
| Hepatic Function Abnormal |
2.8% |
| Liver Disorder |
2.8% |
|
